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• P.mirabilis is a motile gram-negative bacterium that differentiates
from a short vegetative rod to an elongated highly flagellated form.
• It is common in long-term catheterization and it is able to form
biofilms on catheters.
• Because of the activation of urease, P. mirabilis can cause
complicated urinary tract infections, like urolithiasis, that is based on
the formation of stones through crystallization.
Introduction [1]
Results 
• The basic crystal morphology is coffin-like (Fig.6, panels
s1 and s2).
• When pH increases, crystals frequently form twins
(Fig.6, panels t1 and t2).
• For highest value of pH 9.5, dendritic structures appear
(Fig.6, panels d1 and d2).
• The typical treatment of urolithiasis concerns antibiotic
therapy. However, the widespread bacterial resistance
shows the need of the development of effective
inhibitors with safe and more potent profiles [2].
Fig. 6. Struvite morphology depending on pH changes on time. Ref. [6].
• P. mirabilis strain was isolated and it was maintained on a slant of tryptic
soy agar overnight at 37ºC. Then, it was suspended in an artificial urine.
• Artificial urine contains: CaCl2·2H2O, MgCl2·6H2O, NaCl, Na2SO4, KH2PO4,
KCl, NH4Cl, Na3C6H5O7, C2Na2O4, (NH2)2CO, C4H9O2N3 and tryptic soy
broth.
• To test the urease inhibitors, it should be added at different
concentrations to artificial urine.
Materials and Methods [2], [3], [4] 
• With a 0,5 mg/ml (3 mM) concentration of AHA, 7-8 hours are
necessary to form the first struvite crystals. It needs 5 mg/ml to
inhibit struvite stone formation. AHA causes side effects [2].
• With a 0,5 mg/ml (3 mM) concentration of vanillic acid, 24 hours are
necessary to form the first struvite crystals (smaller but with the
same morphology) [2].
• With a 0,5 mg/ml (3 mM) concentration of EDTA, 4,5 hours are
necessary to form the first struvite crystals (smaller and with
different morphology, without dendrites) [3].
Fig. 7. Acid vanillic, AHA (Hydroxamic Acid) and EDTA (Ethylenediamine Tetraacetic
Acid) delaying effect on pH. Inhibitors were used at the concentration 0.5 mg/ml (3
mM). Based on Ref. [2] and [3].
• In an artificial urine (with P.mirabilis) without inhibitors, the first struvite crystals are formed at 3 - 4 hours. When inhibitors
are added, the time to form the first struvite crystals is increases.
• Less curcumine concentration is needed than AHA, EDTA and vanillic acid to delay the struvite stones formation.
• Despite AHA is a good urease inhibitor, it is discarded because of side effects.
• So, it could be say that curcumine is the most effective inhibitor. However, it is not because of its low solubility.
• Vanillic acid is more effective than EDTA because with 3 mM of concentration, it allows a greater delay on the formation of
the first struvite crystals. Nevertheless, EDTA is also effective because the stones that forms do not have dendrites, therefore
they are easier to remove.
• Quorum sensing antagonists seem to be good candidates for the urolithiasis treatment because they decrease urease
activity.
• Glycosaminoglycans (GAGs) influence the crystallization but no compound inhibit this process. So, GAGs don’t prevent the
formation of struvite crystals. GAGs are molecules that have an influence on the adhesion of crystals to urothelium.
• Crystals morphology are mainly influenced by the rate of change in pH with minor
influence on the value of pH.
• Aggregation is one of the main causes of stone formation in the urinary tract.
• Molecules such as polyphenols, quorum sensing antagonists and other chemical
molecules are replacing the role of antibiotics in the treatment and prevention of
urolithiasis.
• The use of GAGs replacement therapy is investigated for the treatment of
urolithiasis.
• Fluorofamide fails to inhibit cytoplasmic urease, so it is not useful for treating
urolithiasis produced by P. mirabilis.
• Research about urease inhibitory mechanism of quorum sensing antagonists is
required.
• One of the urease inhibitors seems to be the most effective for the treatment of
urolithiasis is vanillic acid, followed by EDTA.
Discussion Conclusions
UREASE INHIBITOR CRYSTALLIZATION INFLUENCE
Fluorofamide [8] • Fails to inhibit cytoplasmic ureases.
Curcumine [4]
• With a concentration of 1 mM, 10 hours are
required to form the first struvite crystals (fewer
and smaller but with the same morphology).
• Low solubility.
TA and PNPG [9]
• There are a quorum sensing antagonists.
• In the presence of 100 – 200 µg/ml, biofilms
possess a significantly lower number of bacterial
cells, decreasing the pH of 8.3-8.4 to 6.1-6.7.
GAGs [10]
• ChSC increases the crystallization.
• All GAGs intensified the struvite stones
adhesion to ureter and kidney urothelium.
Adhesion to bladder urothelium was not
promoted neither by HS nor ChSB.
• ChSA showed an increment of adherence to
three urotheliums (ureter, bladder and kidney).
Table 1. Crystallization effect of different urease inhibitors. TA (Tannic Acid), PNPG (p-
nitrophenyl glycerol), GAGs (Glycosaminoglycans), ChSC (Chondroitin Sulfate C), HS
(Heparan Sulfate), ChSB (Chondroitin sulfate B), ChSA (Chondroitin Sulfate A).
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• P. mirabilis urease is a cytoplasmic metaloenzim
• It is a multimeric enzyme composed by three structural subunits (γ, β and
α). These polypeptides are encoded by three structural genes (ureA, ureB
and ureC respectively).
• Additional proteins (UreD, UreE, UreF and UreG), products of accessory
genes, are required for urease activation
Urease activation Stone formation (Urolithiasis)                                                                           P. mirabilis persistence in stones
Fig. 3. Urea degradation. Modification of Ref. [5].
Fig. 4. Carbonate apatite (CA) and Struvite (S) grown from artificial urine in
the presence of P.mirabilis. Modification of Ref. [6]. Fig. 5. P.mirabilis persistence in the stones. Modification of Ref. [7].




Proteus mirabilis urease  [5]




3- ions occurs [6].
pH ≥ 6,8
pH ≥ 7,2
• Define P.mirabilis and its role in urolithiasis.
• Define P.mirabilis urease constitution and its
regulation.
• Explain the stone formation in the urinary tract
focusing on the P.mirabilis persistence.
• Explain different urease inhibitors to treat the
urolithiasis.
Objectives
